D'AGE Sheep Placenta Extract / Stem Cell Therapy D'AGE is one of our most precious project, we created the environment and incorporated sand glass into the visual, all the sand effects details was crafted with a lot of TLC. By: ExpressoFX … Continue reading →

Hackensack, NJ (PRWEB) October 31, 2013 The program is meant for parents and health professionals alike. Continuing education credits for New Jersey nurses will be provided. Invited speaker and childhood epilepsy expert, Dr. John Pellock will discuss epilepsy emergencies in children, new medications for epilepsy and future therapies. He is joined by an exceptional group of epilepsy specialists who will lecture on new advances in diagnosis and treatment of epilepsy, epilepsy surgery, autism and epilepsy, infantile spasms, Tuberous Sclerosis, Lennox Gastaut Syndrome, Dravets Syndrome, and genetics in epilepsy. The Epilepsy Foundation of New Jersey will share know-how and local resources for parents and health providers. The conference is free of charge and is taking place on November 8 at the Hackensack University Medical Center at 30 Prospect Ave. Hackensack, NJ 07601--Hekemian Auditorium and Hekemian Conference Room 1 and will run from 9AM to 4PM. Breakfast and lunch are provided. To register, email events(at)epilepsygroup(dot)com, go to http://epilepsygroup.com/news_patients_providers6-20-2-142/what-you-need-to-know-if-epilepsy-has-touched-your-life.htm or call 201-643-6676. Dr. Marcelo Lancman, Director of Northeast Regional Epilepsy Group and board certified epileptologist, commented: This year we launched our second very ambitious educational program called What You Need to Know if Epilepsy Has Touched Your Life aimed to raise epilepsy and … Continue reading →

Published on: Thursday, October 31, 2013 By Bonnie Katz The U.S. Food and Drug Administration has approved clinical trials of a cannabis-based drug and its effects on epilepsy. The treatment, Epidiolex, is 98 percent purified cannabidiol (CBD) made by GW Pharmaceuticals based out of the U.K. There are around 60 known chemicals contained in cannabis called cannabinoids. Tetrahydrocannabinol, also known as THC, is the main component responsible for the drugs psychoactive nature. CBD, however, is the second most abundant cannabinoid in the cannabis and provides medicinal benefits without the high. Epidiolex will come in a viscous liquid form to be dispensed from syringes. A 25 milligram per meter or 100 milligram per meter will be the two strengths made available to those in the trials. The FDA has approved of intermediate-sized clinical trials sponsored by two doctors. Dr. Orrin Devinsky, a professor in the Department of Neurology, Neuroscience and Psychiatry in the New York University School of Medicine and director of the NYU Comprehensive Epilepsy Center, and Dr. Roberta Cilio, a pediatric neurologist at the University of California, San Francisco, are set to follow 25 patients using Epidiolex as treatment for pediatric epilepsy. On Oct. 4, at the NYU Langone … Continue reading →

Los Angeles, Ventura, Santa Clarita, CA (PRWEB) October 31, 2013 Autism services organization, Working With Autism Inc. announced the start of a new Specialized Respite Services program. The service was designed to offer professional temporary relief to family members or other caregivers of children with autism. Working With Autisms launch of the program is aimed at further fostering well-being in the hundreds of families they serve. While in the WWA program, the client is provided with in-home, non-medical care, promoting their basic self-help needs and participation in other activities, while family members or caregivers are given a personal break from their role to attend to errands and appointments, engage in social activities or just take time for themselves. Dr. Hilya Delband, Director of Clinical Development and Marketing, explained what sets this service apart from the usual caregiving experience: Our respite care staff have training in applied behavior analysis (ABA) techniques and are therefore better equipped to manage any behavioral challenges that may arise when caring for a child with autism. In addition to having specialized behavioral education, WWA respite service staff hold current CPR and First Aid certifications and maintain regular crisis prevention intervention training to insure the safety of … Continue reading →

Released: 10/30/2013 6:00 PM EDT Source Newsroom: Mayo Clinic Newswise LEBANON, NH - For someone having a stroke, minutes can make the difference between life and death. Studies have shown that prompt access to a vascular neurologist vastly reduces mortality or the long-term disabling effects of a stroke. Yet, many hospitals, particularly in rural regions, do not have a stroke specialist or are unable to provide around-the-clock stroke coverage. To address this problem, Dartmouth-Hitchcock (D-H), in collaboration with Mayo Clinic, has created a telestroke program, offering participating hospitals across New Hampshire and Vermont 24/7 access to specialists. In telestroke care, specialists at a distance use videoconferencing technology to communicate with the emergency room team, examine the patient, interpret the brain images, confirm the diagnosis, and provide recommendations just as if they were at the bedside. This thorough evaluation determines the most-immediate and best treatment plan for that patient. Additionally, research has shown that telestroke programs improve outcomes, reduce patient risks, decrease ambulance transport, shorten hospital stays, and lower costs through more timely and accurate diagnosis. Telehealth is critical to creating a sustainable health system that focuses on population health, value, and payment models that reward high-quality care, said James N. … Continue reading →